Pharmaceutical PV DIV - FSB
Ended Awarded
- Contract number
- SPE2DU26FENWU
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,766
Award facts
- Contract value 100% obligated
- $12,766.02 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $12,766.02 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, on October 28, 2025, with an ultimate completion date of October 29, 2025. This firm fixed-price delivery order carries no set-aside designation, reflecting DMS Pharmaceutical Group's competitive capability in unrestricted federal procurement. The award is issued under the company's single-award Indefinite Delivery Contract (IDC) designated SPE2DR, awarded under the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative on November 13, 2025, with a $499.999 billion ceiling value extending through December 31, 2036.
DMS Pharmaceutical Group serves as a critical pharmaceutical supplier for Department of Defense healthcare operations, delivering a comprehensive range of branded and generic prescription medications, over-the-counter drugs, biologics, vaccines, and medical consumables to military healthcare facilities worldwide. The company's product portfolio includes oncology treatments, immunosuppressants, emergency medications, specialty surgical products, vaccines, and routine pharmaceuticals. The PPV-G GEN V program, a $30.3 billion acquisition strategy, establishes multiple regional prime vendor contractors to support recurring medical supply needs across the military medical system. DMS Pharmaceutical Group's substantial federal contracting activity and demonstrated performance across numerous delivery orders position it as a key provider within the Department of Defense's pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DU26FENWU?
SPE2DU26FENWU was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 28, 2025.
How much is contract SPE2DU26FENWU worth?
The government has obligated $12,766 on SPE2DU26FENWU.
Is contract SPE2DU26FENWU an order under another contract?
Yes. SPE2DU26FENWU is a delivery order under SPE2DU25D9418, an indefinite delivery contract.
Was contract SPE2DU26FENWU competed?
The extent of competition for SPE2DU26FENWU was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award